Quince Therapeutics Inc.

QNCX | NASDAQ

Price Alert Chart Builder DCF Calculator

$31.62

+$0.62 (+2.00%)

Sep 22, 2026, 11:11 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $8.63M

Enterprise Value $-107.35M

Beta 1.31

Average Volume 56.48K

Shares Outstanding (Diluted) 6.13M

Shares Change YoY 2527.26%

Institutional Ownership 1.18%

Exchange NASDAQ

ISIN US22053A3059

Price Performance

Price Change 1M -3.4%

Price Change 3M 60.1%

Price Change 6M 52.0%

Price Change YTD -94.8%

Price Change 1Y -90.4%

Price Change 3Y -86.5%

Price Change 5Y -99.8%

1M CAGR (ann.) 2.6%

1Y CAGR (ann.) -90.4%

5Y CAGR (ann.) -71.8%

All-Time CAGR -51.6%

Valuation

PE Ratio -0.45

Forward PE N/A

PEG Ratio -0.02

Forward PEG 0.01

PS Ratio N/A

Forward PS 0.50

PB Ratio 0.08

P/FCF Ratio -0.18

P/Adj. FCF Ratio -0.14

P/OCF Ratio -4.05

EV/Sales N/A

EV/EBIT 5.62

EV/EBITDA 1.40

EV/FCF 2.28

Earnings Yield -222.3%

FCF Yield -544.6%

Adj. FCF Yield -727.9%

Financial Health

Net Cash $115.98M

Total Debt $0

Cash & Short-Term Investments $115.98M

Total Assets $124M

Current Ratio 14.52

Quick Ratio 14.52

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -4.71

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -33.7%

Returns

Return on Assets -74.6%

Return on Equity -413.3%

Return on Invested Capital -104.6%

Return on Capital Employed -107.1%

Return on Tangible Assets -74.6%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 51.3%

EPS CAGR 5Y 36.2%

EPS CAGR 10Y N/A

FCF CAGR 3Y -25.5%

FCF CAGR 5Y 4.2%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 11

EPS Growth Next 3Y 30.8%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$1.13

EPS Growth Est (next Q) -97.8%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $69

Price Target Upside 122.6%

Cash Flow

Operating Cash Flow $-46.92M

Free Cash Flow $-47M

Adj. Free Cash Flow $-62.83M

FCF Per Share -$7.66

OCF Per Share -$7.65

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-59.04M

Operating Income $-65.98M

EBITDA $-76.7M

Net Income $-92.48M

EPS (Diluted) -$68.91

Revenue / Employee N/A

Profit / Employee $-2.43M

Employees 38